Area of research
Oncology · Hepatology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, Sarcoma Diagnosis and Treatment, and Cholangiocarcinoma and Gallbladder Cancer Studies.
Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trial
Cryoablation-induced neutrophil Ca2+ elevation and NET formation exacerbate immune escape in colorectal cancer liver metastasis
Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity
Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
Research progress on anti-tumor immune effect of cryoablation
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
Intermediate stage hepatocellular carcinoma
[The combination of YAP/TAZ predicts the clinical prognosis in patients with cholangiocarcinoma after radical resection].
Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma
Deep Learning Approach for Markerless Pancreatic Tumor Target Localization
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma
Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma